Nova Leap Health Corp.
NLH.V
TSX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 22.15% | 16.47% | 8.63% | 0.81% | -1.60% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 22.15% | 16.47% | 8.63% | 0.81% | -1.60% |
| Cost of Revenue | 19.59% | 14.69% | 7.34% | -0.24% | -3.27% |
| Gross Profit | 26.27% | 19.32% | 10.70% | 2.52% | 1.21% |
| SG&A Expenses | 24.95% | 19.79% | 13.90% | 6.00% | 0.19% |
| Depreciation & Amortization | 42.70% | 25.98% | 2.46% | -21.35% | -34.04% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 21.95% | 16.69% | 9.39% | 1.14% | -3.20% |
| Operating Income | 28.07% | 10.93% | -11.02% | -9.35% | 87.68% |
| Income Before Tax | -107.28% | 311.09% | 71.03% | 371.41% | 232.65% |
| Income Tax Expenses | -86.67% | 1,610.34% | 339.02% | 334.89% | 239.25% |
| Earnings from Continuing Operations | -113.77% | 262.21% | -7.71% | 390.52% | 230.70% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -113.77% | 262.21% | -7.71% | 390.52% | 230.70% |
| EBIT | 28.07% | 10.93% | -11.02% | -9.35% | 87.68% |
| EBITDA | 36.41% | 15.99% | -7.05% | -17.24% | 6.15% |
| EPS Basic | -112.88% | 267.27% | 46.15% | 394.12% | 233.61% |
| Normalized Basic EPS | -100.00% | 55.93% | -53.13% | 122.00% | 2,257.14% |
| EPS Diluted | -114.29% | 245.76% | 160.00% | 323.81% | 222.22% |
| Normalized Diluted EPS | -100.00% | 52.54% | -55.21% | 118.00% | 2,228.57% |
| Average Basic Shares Outstanding | 2.46% | -0.66% | -0.98% | -0.54% | -0.21% |
| Average Diluted Shares Outstanding | 2.10% | 0.05% | -0.74% | -0.30% | 0.03% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |